🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementThe nausea is gone at month 3 - there IS a light at the end

The nausea is gone at month 3 - there IS a light at the end

tampaLisa73 Mon, Apr 6, 2026 at 3:07 AM 29 replies 852 viewsPage 1 of 6
tampaLisa73
Member
312
1,456
Oct 2024
Tampa, FL
Apr 6, 2026 at 3:07 AM#1

Nausea arrived on day two of each dose step, lasted about four days, and disappeared entirely by the second week — until the step where it did not.

What would genuinely help is knowing what distinguishes the nausea you can titrate through from the nausea that means stop.

Practical detail welcome, however dull — the duller the better.

36 6RunnerRach, TrialNerd_Beth, HPLC_Greg and 33 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Apr 6, 2026 at 5:35 AM#2

This one has a reasonably settled answer, so here it is. Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts. Receptor-level tachyphylaxis to the delayed-emptying effect develops over weeks while the central appetite effect persists, so the same dose is materially more comfortable at week six than at week two. A slower ladder therefore reaches the same dose with less cumulative nausea, not the same nausea spread thinner.

35 5roxy_nash, tony_orlando, Dr.NephBHM_UK and 32 others
Reply Quote Save Share Report
SandraNC_45
Member
312
1,345
Sep 2024
Charlotte, NC
Apr 6, 2026 at 8:03 AM#3
BariatricNurseD said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

Agreeing with BariatricNurseD, and the qualification matters more than the agreement. The meal advice is right and incomplete without the hydration point. People stop drinking because drinking makes them feel full, then attribute dehydration symptoms to the drug.

34 4NicoleRaleigh, james_edin, FranDenver and 31 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
hannah_MT
New Member
23
89
Feb 2026
Bozeman, MT
Apr 6, 2026 at 10:31 AM#4
tampaLisa73 said:
Nausea arrived on day two of each dose step, lasted about four days, and disappeared entirely by the second week — until the step where it did not.

Can confirm the pattern tampaLisa73 describes. The line between titrate-through and stop is not severity, it is trajectory and what else is present. Nausea that peaks and improves within a week is the expected pattern. Nausea that is escalating, or that comes with severe upper-abdominal pain radiating to the back, or that prevents fluids for more than a day, is a different conversation and belongs with a clinician the same day.

33 3PurityPaulOR, MaxMetOK, MounjBrad and 30 others
Reply Quote Save Share Report
sean_dublin
Member
212
890
Nov 2024
Dublin, IE
Apr 7, 2026 at 1:17 AM#5

Adding the clinical framing, because it changes how the question reads. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

32 2quinn_sf, NurseLeah_Nash, gary_naperville and 29 others
Reply Quote Save Share Report
1236

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register